Projects Funded

Home » Funded Projects

2024

dr daniel stover md

Daniel G. Stover, MD

The James, The Ohio State University
Dr. Lori Gill-Grennan Inflammatory Breast Cancer Fund

This funding supports education, research, and clinical activities for inflammatory breast cancer and/or program promotion or operational costs related to the inflammatory breast cancer program at Ohio State University. The research funded under this effort is Dr. Daniel Stover.

2023

marissa n rylander phd

Marissa N. Rylander, PhD.

The University of Texas

The project will develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

Melika Mehrabi Dehdezi, BSc

Melika Mehrabi Dehdezi, BSc

The University of Texas

PhD. student conducting the research with Marissa N. Rylander, PhD. to develop the first Breast-Skin microfluidic experimental platform to dynamically and spatially measure cancer cell invasion into the dermal layer, skin lymphatics, and breast vasculature characteristic of IBC. This platform will be employed to determine the cellular components and tissue properties that drive IBC cancer cell migration to enable development of potential treatments and preventive strategies.

Justin Balko, Pharm.D., Ph.D

MD Anderson boot walk to end cancer

The University of Texas MD Anderson Cancer Center

Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.

Dana Farber Jimmy Fund Walk

Dana Farber Jimmy Walk

Dana Farber Cancer Institute

Matching grant for the annual Jimmy Fund Walk to support cancer care and cancer research at Dana Farber Institute.

2022

dr daniel stover md

Daniel G. Stover, MD

The James, The Ohio State University
Dr. Lori Gill-Grennan Inflammatory Breast Cancer Fund

This funding supports education, research, and clinical activities for inflammatory breast cancer and/or program promotion or operational costs related to the inflammatory breast cancer program at Ohio State University. The research funded under this effort is Dr. Daniel Stover.

Justin Balko, Pharm.D., Ph.D

Justin Balko, Pharm. D., Ph.D.

Vanderbilt-Ingram Cancer Center

Justin Balko, Pharm.D., Ph.D.  and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer.  In addition,  Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.

Justin Balko, Pharm.D., Ph.D

Carlos L. Arteaga, M.D.

Vanderbilt-Ingram Cancer Center

Justin Balko, Pharm.D., Ph.D.  and Carlos L. Arteaga, M.D. The goal of this grant is to utilize existing models of inflammatory breast cancer.  In addition,  Vanderbilt investigators were the first to identify and explore a particular variance – amplification of the JAK2 gene.

Justin Balko, Pharm.D., Ph.D

Continuing Medical education

Baylor College of Medicine

Sponsorship for this CME aimed to enhance the knowlege of oncologists in the management of advanced breasta cancer and how to implement the emerging therapies and cuttin edge techniques into day to day practice. 

Justin Balko, Pharm.D., Ph.D

MD Anderson boot walk to end cancer

The University of Texas MD Anderson Cancer Center

Matching grant for this annual fundraiser that provides support for patient programs, research, prevention and education at MD Anderson — and 100% of funds raised by participants directly support MD Anderson’s mission to end cancer.

Justin Balko, Pharm.D., Ph.D

7th international inflammatory breast cancer symposium

The University of Texas MD Anderson Cancer Center

This two-day meeting is targeted for clinical investigators, physicians, basic researchers, nurses, patient advocates and institutions aiming to pioneer IBC clinics in their geographic regions, to enhance their knowledge and to facilitate collaboration to accelerate clinical therapy and research trial development beneficial for patients with IBC. We expect new ideas and collaborations from this meeting to lead to improvement of disease outcome, such as survival or tumor response, over the next 3 years.

Justin Balko, Pharm.D., Ph.D

The James

The James Cancer Hospital’s Stefanie Spielman Comprehensive Breast Center

The James Cancer Hospital’s Stefanie Spielman Comprehensive Breast Center recently launched an inflammatory breast cancer (IBC) program. The IBC program is the first in the state of Ohio and one of only a handful in the nation. Proceeds from our fundraiser will be used for research on why inflammatory breast cancer has such a unique pattern or spread and aggressive course. 

Translate »

Pin It on Pinterest

Share This